Presentation
Generation of chimeric antigen receptors (CARs) based on peptide-selective monoclonal antibodies with unique TCR-like properties to control Epstein-Barr virus-associated tumors
Author
Date:
05-31-2017 ,
Time:
11:10 am
|
Topic: Immunotherapy
Presentation
Newly identified naturally processed and presented EBV-derived T-cell epitopes are highly immunodominant targets in adoptive immunotherapy for PTLD and EBV-infections
Speaker
Date:
06-02-2017 ,
Time:
09:40 am
|
Topic: Assembly